worried about intra days and tomorrow's sp and the day after. FFS people, if you want to 10 bag plus, you have to look longer term..the daily ups and downs are just noise. The bb will be full of traders for the next few days trying to buy and sell every dip. Learn to assess the longer implications and sit tight...even 10 or 15% either way daily s irrelevant so long as the trend is up..which it is, and will continue to be
The news on Thursday is massively significant. The rise has nowhere near factored in what will be happening here over the next few months. Phase 1...Real time covid detection in water..this is how the world will get back on its feet. Early detection with real time monitoring...how big is that industry worldwide? To get some sort of idea..just look at what the cruise industry is worth on its own. Then think hospitals, buildings of mass occupation i.e schools, Universities, all public buildings etc. Partners already in place in U.S and China. 3000 MWG units ready and waiting to retrofit the new device too. Starting to get the picture? Oh, and then there's real time or sub 30 second above ground monitoring..phase 2. What will that be? Possible a breathalyser type device to detect Covid in a few seconds on someones breath? Phase 2 is a guess but GB has something up his sleeve and Phase 1 is a billion pound company in the making on its own. The right technology, at the right time ,with the right partners...it doesn't get much better on Aim. Sit back and watch this develop..that's what I've been saying and doing for the last 3 years. Oh yes, plus labskin and that huge business in its own right. 75M M/Cap....peanuts
I don't need to defend it you good because the business model is completely changing. What part of that do you not understand? Ohh Gerard, please merge with MWG and run it exactly like it has been run for the last few years please! What was Integumen like when GB took the helm Muggins? Do some bloody research, open your eyes and stop your constant whining..or sell tfu..You own your investment don't you? Or are you using your mums account..jesus
Sell up then Gell..there's a button that says sell..it's really simple. ODX is only designed for people that don't wet the bed when they don't have constant news. GDR is full of news..it had an update...mmm..let me think.. at least 3 months ago. Lose the moment? mmm..let me think..the opportunity for world wide antigen and antibody tests is nearly over? Great post Gell..
Muggins..you don't know why because you don't have the knowledge. Your best bet will be either sell up or trust in the intelligent people that do know what the pipeline and future holds, and stop wetting the bed. For somebody to constantly moan about a share they're invested in by choice, really shows what a complete idiot you must be. Why would somebody actually bother to do that? Are there no other shares you can find in the whole of the stock market to put your pittance in and save everyone else having to read your constant waffle?
The MWG business model is changing. The merger will go ahead and big ticket items will not be sold any more. It will be about smaller water monitoring tech with higher volume and recurring revenues. What's gone on to date is now history..onwards and upwards
Fancy joining our team in bonnie Scotland?Flag of Scotland
We're looking for an experienced Sales Order Processor to join the Supply Chain team. This is a full-time position based in Alva, Scotland, at the foot of the beautiful Ochil Hills.
Interested? DM us for more info on how to apply.
for disrupting the BB...if enough people do it they'll ban him. He's clearly completely clueless and is literally only on here to wind people up...either that or filter the tool...he'll be going to school in a minute so will stop posting until half 3
ADV11..completely wrong chap I'm afraid. If their portfolio becomes too weighted due to price increase they have to sell down...they're not some PI that personally decides when to hold and when to buy..do you not have a clue about how 2's work and their balanced portfolio risk management?
All the MHRA are signing off is the ease of use of the product..the accuracy and lab test is already approved. They had 2000 people use it in their cars over the weekend..what was the combined feedback from them? Is it capable to be sent out to members of the public to be used properly..i.e Can they read simple instructions and prick one of their fingers? We know it's **** easy to use..it just needs rubber stamping...won't take long.
getting involved in Omega now and they're usually ultra pessimistic about small caps..just the 100% upside for them..
Omega Diagnostics share price: need-to-know
The coronavirus pandemic has been a boon for Omega. The company is planning to produce as many as five different types of Covid-19 tests.
The self-test usability study for one of these, the AbC-19 Rapid Test, was completed last weekend. This put the product one step closer to coming to market.
As well as the Rapid antibody Test, at the beginning of September, Omega’s Mologic Covid-19 lateral flow antibody test was awarded its CE Mark. This quality marking means the business can now start marketing and selling the product.
These Covid tests are not the only strings to Omega’s bow. The group has three operating segments. As well as the coronavirus testing segment, there’s a division specialising in allergies and food intolerances. The third segment provides HIV testing equipment. This provides some diversification for the business.
Unfortunately, the company remains in its early stages. It’s not yet self-sufficient, which could be a red flag for investors looking at the Omega Diagnostics share price.
Earlier this year, the group raised £11m from investors to scale up production. While demand for the company’s products will provide much-needed cash flow, I wouldn’t rule out another cash raise in future as the business finds its feet.
Still, despite this drawback, it’s clear the business has tremendous potential.
Financial broker finnCap reckons Omega could ultimately be looking at £8m-£12m of revenue from its food intolerance testing business and £37m in revenues from Covid test sales. The group’s HIV test, VISITECT CD4, could be worth between £45m to £75m.
Based on these projections, the Omega Diagnostics share price looks cheap after its recent performance.
In the best case, the projections above suggest the business has the potential to generate £124m in annual revenues. Quest Diagnostics Inc is one of the largest testing companies in the world. And that stock is currently trading at a multiple of two times sales.
Based on this, it’s not unreasonable to suggest Omega could be worth as much as £248m in the best-case scenario.
However, I should stress this is the best-case scenario. The company is still finding its way, and a lot could wrong between now and annual sales of £124m.
That said, it’s clear there’s a tremendous amount of potential here. With upside potential as much as 100%, investors could be well rewarded if the company gets everything right.
Therefore, the best solution may be to own the stock as part of a diversified portfolio. Doing so would minimise downside risk while providing exposure to profits if the Omega Diagnostics share price continues to surge in value.
on the LOI without even thinking what the added value is for ORCP. Hold from here for18 months and what do you think the sp will be with other projects thrown into the mixer. You don't get this calibre of people involved and Sheikhs chucking millions in without big returns...bet many people won't be around in that time frame but that's where the serious money is to be made...